Cargando…

Low-dose Aspirin for Primary Prevention of Cardiovascular Events in Postmenopausal Women with Type-2 Diabetes: The Prescriptive Approach in the Real World

BACKGROUND: The long-term efficacy of low-dose aspirin for primary prevention of cardiovascular (CV) events in postmenopausal women with type-2 diabetes is controversial. Therefore, it is recommended only on an individual basis, recommendation of grade C. METHODS: We enrolled 275 consecutive postmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maiello, Maria, Cecere, Annagrazia, Zito, Annapaola, Ciccone, Marco Matteo, Palmiero, Pasquale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631123/ https://www.ncbi.nlm.nih.gov/pubmed/34912516 http://dx.doi.org/10.4103/ijpvm.IJPVM_365_19

Ejemplares similares

Metabolic syndrome and breast cancer: a dangerous association for postmenopausal women. A postmenopausal women prevention study
por: Maiello, Maria, et al.
Publicado: (2021)

How Aortic Stiffness in Postmenopausal Women Is Related to Common Cardiovascular Risk Factors
por: Maiello, Maria, et al.
Publicado: (2014)

Primary Prevention of Cardiovascular Risk in Octogenarians by Risk Factors Control(#)
por: Palmiero, Pasquale, et al.
Publicado: (2019)

Left Ventricular Diastolic Function in Hypertension: Methodological Considerations and Clinical Implications
por: Palmiero, Pasquale, et al.
Publicado: (2015)

A three-dimensional electronic report of a venous echo color Doppler of the lower limbs: MEVeC(®)
por: Galeandro, Aldo Innocente, et al.
Publicado: (2014)

Ivabradine, coronary artery disease, and heart failure: beyond rhythm control
por: Scicchitano, Pietro, et al.
Publicado: (2014)

Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy
por: Parato, Vito Maurizio, et al.
Publicado: (2016)

Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study
por: Zhou, Qiongjie, et al.
Publicado: (2023)

Prescription of Aspirin for adults with Diabetes
por: Sabitha, P., et al.
Publicado: (2008)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
por: Christensen, Mikkel B., et al.
Publicado: (2021)

Effects of a Low Carb Diet and Whey Proteins on Anthropometric, Hematochemical, and Cardiovascular Parameters in Subjects with Obesity
por: De Pergola, Giovanni, et al.
Publicado: (2020)

Coronary artery disease, left ventricular hypertrophy and diastolic dysfunction are associated with stroke in patients affected by persistent non-valvular atrial fibrillation: a case-control study
por: Palmiero, Pasquale, et al.
Publicado: (2009)

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
por: Sylvester, Katelyn W, et al.
Publicado: (2013)

The Effect of Low-Dose Aspirin on Frailty in Older Adults in the Aspirin in Reducing Events in the Elderly Study
por: Espinoza, Sara, et al.
Publicado: (2021)

Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study
por: Iacono, Daniela, et al.
Publicado: (2019)

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
por: De Berardis, Giorgia, et al.
Publicado: (2007)

Life-threatening acute myocardial infarction due to left main dissection during radiofrequency transcatheter ablation of atrial tachycardia
por: Cafaro, Alessandro, et al.
Publicado: (2019)

Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
por: Djatche, Laurence M., et al.
Publicado: (2018)

Dietary Intake of Carotenoids and Their Antioxidant and Anti-Inflammatory Effects in Cardiovascular Care
por: Ciccone, Marco Matteo, et al.
Publicado: (2013)

Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting
por: Carlton, Rashad, et al.
Publicado: (2018)

Testosterone treatment and cardiovascular events in prescription database studies
por: Shores, Molly M
Publicado: (2018)

Effect of Exercise Prescription Implementation Rate on Cardiovascular Events
por: Zhu, Li-Yue, et al.
Publicado: (2022)

Lung function and side effects of Aspirin desensitization: a real world study
por: Turpeinen, Heikki, et al.
Publicado: (2021)

The Use of Aspirin Increases the Risk of Major Adverse Cardiac and Cerebrovascular Events in Hypertensive Patients with Obstructive Sleep Apnea for the Primary Prevention of Cardiovascular Disease: A Real-World Cohort Study
por: Li, Nanfang, et al.
Publicado: (2022)

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real‐world evidence
por: Toth, Peter P., et al.
Publicado: (2019)

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
por: Johnson, Ben, et al.
Publicado: (2021)

Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
por: Kim, Ae Jin, et al.
Publicado: (2014)

Low dose aspirin and pregnancy: how important is aspirin resistance?
por: Navaratnam, K, et al.
Publicado: (2016)

Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World Data
por: Chi, Nai‐Fang, et al.
Publicado: (2018)

Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study
por: Li, Hu, et al.
Publicado: (2020)

Pattern of triptans use: a retrospective prescription study in Calabria, Italy
por: Scuteri, Damiana, et al.
Publicado: (2020)

Osteoporosis Prevention and Treatment: The Risk of Comorbid Cardiovascular Events in Postmenopausal Women
por: Gilbert, Zachary A, et al.
Publicado: (2022)

Platelets, Aspirin and Cardiovascular Disease
por: Elwood, P. C.
Publicado: (1976)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Pros and Cons of Aspirin Prophylaxis for Prevention of Cardiovascular Events in Kidney Transplantation and Review of Evidence
por: Khalil, Muhammad Abdul Mabood, et al.
Publicado: (2019)

Exercise Prescription and the Minimum Dose for Bone Remodeling Needed to Prevent Osteoporosis in Postmenopausal Women: A Systematic Review
por: Koshy, Feeba Sam, et al.
Publicado: (2022)

Validation of low‐dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over‐the‐counter use?
por: Cea Soriano, Lucía, et al.
Publicado: (2015)

Thrombotic Events Associated to Aspirin Therapy
por: Doutremepuich, Christian, et al.
Publicado: (2012)

Big Data in cardiac surgery: real world and perspectives
por: Montisci, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48iire93g4oqn18idfu51daf7k